Metanavigation:

Hier finden Sie den Zugang zur Notfallseite, Kontaktinformationen, Barrierefreiheits-Einstellungen, die Sprachwahl und die Suchfunktion.

Navigation öffnen
Eine Mann füllt mit einer Pipette eine rote Flüssigkeit in ein kleines Glas

Research group - Clinical and translational precision oncology

Every cancer is unique. Precision oncology aims at identifying personalized treatment options through molecular cancer profiling. In our group, we focus on creating reproducible and evidence-based individualized treatment options.

Sie befinden sich hier:

How patients can benefit through our research

For our ultimate goal to improve treatment strategies we directly translate molecular profiling technologies from routine panel sequencing and immunohistochemistry to multi-omics analyses into clinical care through the weekly Charité molecular tumor conference. Here we bring our latest results from analyzing clinical and molecular data and knowledge of the mechanisms of tumor biology to the table and discuss “real life cases” with a variety of experts.

Research topics


Clinical precision oncology

Since every cancer is unique, reproducible and evidence-based decision-making is a challenge in precision oncology. We collaborate in several national and international working groups to streamline workflows, evidence levels and databases to help translate molecular profiles into personalized treatment using the best available data.


Translational precision oncology

The combined analysis of clinical and molecular data allows for an in-depth analysis of mechanisms underlying response and resistance to personalized therapies. We aim at harnessing these data to improve understanding of tumor biology and ultimately identify novel treatment strategies.


Team - Clinical and translational precision oncology

Prof. Dr. med. Ulrich Keilholz

Direktor des Charité Comprehensive Cancer Center, Charité

Prof. Dr. med. Ulrich Keilholz
Dr. med. Damian Rieke

Ärztlicher Mitarbeiter | Sprecher der AG Präzisionsonkologie